Victor Sandor
Director/Board Member at MERUS N.V.
Net worth: 261 969 $ as of 2024-03-30
Victor Sandor active positions
Companies | Position | Start | End |
---|---|---|---|
MERUS N.V. | Director/Board Member | 2019-06-11 | - |
Independent Dir/Board Member | 2019-06-11 | - | |
ADC THERAPEUTICS SA | Director/Board Member | 2020-04-26 | - |
Independent Dir/Board Member | 2020-04-26 | - | |
PRELUDE THERAPEUTICS INCORPORATED | Director/Board Member | 2020-04-30 | - |
Independent Dir/Board Member | - | - | |
KYMERA THERAPEUTICS, INC. | Director/Board Member | 2022-11-02 | - |
Independent Dir/Board Member | 2022-11-02 | - | |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Director/Board Member | 2019-06-30 | - |
Career history of Victor Sandor
Former positions of Victor Sandor
Companies | Position | Start | End |
---|---|---|---|
INCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 2009-12-31 | 2019-08-31 |
ARRAY TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 2014-09-21 | 2019-07-31 |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Corporate Officer/Principal | 2010-01-31 | 2014-08-31 |
Training of Victor Sandor
McGill University | Doctorate Degree |
Statistics
International
United States | 7 |
Canada | 2 |
Netherlands | 2 |
Operational
Director/Board Member | 5 |
Independent Dir/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoral
Health Technology | 9 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 5 |
---|---|
INCYTE CORPORATION | Health Technology |
MERUS N.V. | Health Technology |
ADC THERAPEUTICS SA | Health Technology |
PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
KYMERA THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Health Technology |
- Stock Market
- Insiders
- Victor Sandor
- Experience